These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90. Levosimendan as Rescue Therapy for Acute Heart Failure in a Patient with Duchenne Muscular Dystrophy. Sumanaru D; Josseran L; Essid A; Mbieleu B; Haegy I; Bergounioux J Pediatr Cardiol; 2019 Mar; 40(3):668-670. PubMed ID: 30796500 [TBL] [Abstract][Full Text] [Related]
91. Effects of levosimendan without loading dose on systolic and diastolic function in patients with end-stage heart failure. Lunghetti S; Palmerini E; Urselli R; Maffei S; Guarino E; Focardi M; Mondillo S; Favilli R Cardiol J; 2011; 18(5):532-7. PubMed ID: 21947989 [TBL] [Abstract][Full Text] [Related]
92. Prophylactic levosimendan for the prevention of low cardiac output syndrome and mortality in paediatric patients undergoing surgery for congenital heart disease. Hummel J; Rücker G; Stiller B Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011312. PubMed ID: 28262914 [TBL] [Abstract][Full Text] [Related]
93. Prophylactic levosimendan for the prevention of low cardiac output syndrome and mortality in paediatric patients undergoing surgery for congenital heart disease. Hummel J; Rücker G; Stiller B Cochrane Database Syst Rev; 2017 Aug; 8(8):CD011312. PubMed ID: 28770972 [TBL] [Abstract][Full Text] [Related]
94. Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial. Mebazaa A; Nieminen MS; Packer M; Cohen-Solal A; Kleber FX; Pocock SJ; Thakkar R; Padley RJ; Põder P; Kivikko M; JAMA; 2007 May; 297(17):1883-91. PubMed ID: 17473298 [TBL] [Abstract][Full Text] [Related]
95. Efficacy and Safety of Sacubitril/Valsartan in High-Risk Patients in the PIONEER-HF Trial. Berg DD; Samsky MD; Velazquez EJ; Duffy CI; Gurmu Y; Braunwald E; Morrow DA; DeVore AD Circ Heart Fail; 2021 Feb; 14(2):e007034. PubMed ID: 33530704 [TBL] [Abstract][Full Text] [Related]
96. Influence of levosimendan on organ dysfunction in patients with severely reduced left ventricular function undergoing cardiac surgery. Erb J; Beutlhauser T; Feldheiser A; Schuster B; Treskatsch S; Grubitzsch H; Spies C J Int Med Res; 2014 Jun; 42(3):750-64. PubMed ID: 24781725 [TBL] [Abstract][Full Text] [Related]
97. Repeated infusions of levosimendan: well tolerated and improves functional capacity in decompensated heart failure - a single-centre experience. Parle NM; Thomas MD; Dembo L; Best M; Driscoll GO Heart Lung Circ; 2008 Jun; 17(3):206-10. PubMed ID: 18242130 [TBL] [Abstract][Full Text] [Related]
98. [Levosimendan treatment of severe acute congestive heart failure refractory to dobutamine/milrinone in children]. Prijić S; Rakić S; Nikolić L; Jovicić B; Stajević M; Vukomanović V; Kosutić J Vojnosanit Pregl; 2011 Nov; 68(11):979-84. PubMed ID: 22191317 [TBL] [Abstract][Full Text] [Related]
99. Evaluation of the clinical, hemodynamic and neurohormonal response to levosimendan administration in decompensated heart failure patients. One-month follow-up. Sargento L; Brito D; Matias JS; Madeira H Rev Port Cardiol; 2007; 26(7-8):717-26. PubMed ID: 17939581 [TBL] [Abstract][Full Text] [Related]
100. Levosimendan use in patients with preoperative low ejection fraction undergoing cardiac surgery: A systematic review with meta-analysis and trial sequential analysis. Ng KT; Chan XL; Tan W; Wang CY J Clin Anesth; 2019 Feb; 52():37-47. PubMed ID: 30172838 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]